# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
B. Riley Securities analyst Mayank Mamtani maintains Novavax (NASDAQ:NVAX) with a Buy and raises the price target from $11 t...
https://www.statnews.com/2024/05/22/bird-flu-in-humans-michigan-reports-h5n1-infection-in-dairy-farm-worker/?utm_campaign=rss
Experts predict a small rise in COVID-19 cases as a newly dominant strain spreads. The new strain, KP.2, represents 28% of Covi...
https://www.nbcnews.com/now/video/disease-experts-predict-a-small-rise-in-covid-cases-this-summer-211393605953 Disease experts ...
- Reuters